CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BofA Adjusts Price Target on Beam Therapeutics to $43 From $47

Negative
AI Analysis

Summary

Bank of America reduced its price target on Beam Therapeutics from $47 to $43 per share. This represents a downward revision of the analyst's valuation estimate.

Importance:2/10
Sentiment:
-0.30
price_target_reductionanalyst_downgradeequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 5, 2026 12:15 PM

Read Original